☰

Kyung-Hyun Park-Min, Ph.D. - Publications

Affiliations: 
2007 Weill Cornell Medical College, New York, NY, United States 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hu X, Park-Min KH, Ho HH, Ivashkiv LB. Correction: IFN-γ-Primed Macrophages Exhibit Increased CCR2-Dependent Migration and Altered IFN-γ Responses Mediated by Stat1. Journal of Immunology (Baltimore, Md. : 1950). PMID 36883848 DOI: 10.4049/jimmunol.2300060  0.59
2022 Bae S, Kim K, Kang K, Kim H, Lee M, Oh B, Kaneko K, Ma S, Choi JH, Kwak H, Lee EY, Park SH, Park-Min KH. RANKL-responsive epigenetic mechanism reprograms macrophages into bone-resorbing osteoclasts. Cellular & Molecular Immunology. PMID 36513810 DOI: 10.1038/s41423-022-00959-x  0.666
2022 Murata K, Fang C, Terao C, Giannopoulou EG, Lee YJ, Lee MJ, Mun SH, Bae S, Qiao Y, Yuan R, Furu M, Ito H, Ohmura K, Matsuda S, Mimori T, ... ... Park-Min KH, et al. Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis. Immunity. 55: 2209. PMID 36351378 DOI: 10.1016/j.immuni.2022.10.007  0.557
2022 Bae S, Oh B, Tsai J, Park PSU, Greenblatt MB, Giannopoulou EG, Park-Min KH. The crosstalk between MYC and mTORC1 during osteoclastogenesis. Frontiers in Cell and Developmental Biology. 10: 920683. PMID 36060812 DOI: 10.3389/fcell.2022.920683  0.333
2022 Mun SH, Oh B, Lee MJ, Bae S, Yang Y, Park-Min KH. THOC5 regulates human osteoclastogenesis. European Journal of Cell Biology. 101: 151248. PMID 35688054 DOI: 10.1016/j.ejcb.2022.151248  0.405
2022 Doi K, Murata K, Ito S, Suzuki A, Terao C, Ishie S, Umemoto A, Murotani Y, Nishitani K, Yoshitomi H, Fujii T, Watanabe R, Hashimoto M, Murakami K, Tanaka M, ... ... Park-Min KH, et al. LSD1 metabolically integrates osteoclast differentiation and inflammatory bone resorption through HIF-1α and E2F1. Arthritis & Rheumatology (Hoboken, N.J.). PMID 35077015 DOI: 10.1002/art.42074  0.603
2021 Mun SH, Bae S, Zeng S, Oh B, Chai C, Kim MJ, Kim H, Kalliolias G, Dahia CL, Oh Y, Kim TH, Ji JD, Park-Min KH. Augmenting MNK1/2 activation by c-FMS proteolysis promotes osteoclastogenesis and arthritic bone erosion. Bone Research. 9: 45. PMID 34671034 DOI: 10.1038/s41413-021-00162-0  0.344
2021 Bae S, Park PSU, Lee Y, Mun SH, Giannopoulou E, Fujii T, Lee KP, Violante SN, Cross JR, Park-Min KH. MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. Cell Reports. 35: 109264. PMID 34133930 DOI: 10.1016/j.celrep.2021.109264  0.442
2021 Fujii T, Murata K, Mun SH, Bae S, Lee YJ, Pannellini T, Kang K, Oliver D, Park-Min KH, Ivashkiv LB. MEF2C regulates osteoclastogenesis and pathologic bone resorption via c-FOS. Bone Research. 9: 4. PMID 33424022 DOI: 10.1038/s41413-020-00120-2  0.762
2020 Park PSU, Mun SH, Zeng SL, Kim H, Bae S, Park-Min KH. NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion. Cells. 9. PMID 32967239 DOI: 10.3390/Cells9092133  0.498
2020 Mun SH, Park PSU, Park-Min KH. The M-CSF receptor in osteoclasts and beyond. Experimental & Molecular Medicine. PMID 32801364 DOI: 10.1038/S12276-020-0484-Z  0.453
2020 Bae S, Zeng S, Park-Min KH. Nuclear receptors in osteoclasts. Current Opinion in Pharmacology. 53: 8-17. PMID 32569976 DOI: 10.1016/J.Coph.2020.03.002  0.415
2019 Park-Min KH. Metabolic reprogramming in osteoclasts. Seminars in Immunopathology. PMID 31552471 DOI: 10.1007/S00281-019-00757-0  0.373
2019 Kang K, Bachu M, Park SH, Kang K, Bae S, Park-Min KH, Ivashkiv LB. IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation. Nature Communications. 10: 3320. PMID 31346169 DOI: 10.1038/S41467-019-11147-3  0.806
2019 Kusnadi A, Park SH, Yuan R, Pannellini T, Giannopoulou E, Oliver D, Lu T, Park-Min KH, Ivashkiv LB. The Cytokine TNF Promotes Transcription Factor SREBP Activity and Binding to Inflammatory Genes to Activate Macrophages and Limit Tissue Repair. Immunity. PMID 31303399 DOI: 10.1016/J.Immuni.2019.06.005  0.758
2019 Donlin LT, Park SH, Giannopoulou E, Ivovic A, Park-Min KH, Siegel RM, Ivashkiv LB. Insights into rheumatic diseases from next-generation sequencing. Nature Reviews. Rheumatology. PMID 31000790 DOI: 10.1038/S41584-019-0217-7  0.632
2018 Park-Min KH. Mechanisms involved in normal and pathological osteoclastogenesis. Cellular and Molecular Life Sciences : Cmls. PMID 29670999 DOI: 10.1007/S00018-018-2817-9  0.449
2017 Cao C, Ren Y, Barnett AS, Mirando AJ, Rouse D, Mun SH, Park-Min KH, McNulty AL, Guilak F, Karner CM, Hilton MJ, Pitt GS. Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss. Jci Insight. 2. PMID 29202453 DOI: 10.1172/Jci.Insight.95512  0.364
2017 Park SH, Kang K, Giannopoulou E, Qiao Y, Kang K, Kim G, Park-Min KH, Ivashkiv LB. Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nature Immunology. PMID 28825701 DOI: 10.1038/Ni.3818  0.813
2017 Kang K, Park SH, Chen J, Qiao Y, Giannopoulou E, Berg K, Hanidu A, Li J, Nabozny G, Kang K, Park-Min KH, Ivashkiv LB. Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. Immunity. 47: 235-250.e4. PMID 28813657 DOI: 10.1016/J.Immuni.2017.07.017  0.792
2017 Murata K, Fang C, Terao C, Giannopoulou EG, Lee YJ, Lee MJ, Mun SH, Bae S, Qiao Y, Yuan R, Furu M, Ito H, Ohmura K, Matsuda S, Mimori T, ... ... Park-Min KH, et al. Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis. Immunity. 47: 66-79.e5. PMID 28723554 DOI: 10.1016/J.Immuni.2017.06.018  0.683
2017 Bae S, Lee MJ, Mun SH, Giannopoulou EG, Yong-Gonzalez V, Cross JR, Murata K, Giguère V, van der Meulen M, Park-Min KH. MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα. The Journal of Clinical Investigation. PMID 28530645 DOI: 10.1172/Jci89935  0.43
2016 Huynh L, Kusnadi A, Park SH, Murata K, Park-Min KH, Ivashkiv LB. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Scientific Reports. 6: 31959. PMID 27558590 DOI: 10.1038/Srep31959  0.813
2016 Fang C, Qiao Y, Mun SH, Lee MJ, Murata K, Bae S, Zhao B, Park-Min KH, Ivashkiv LB. Cutting Edge: EZH2 Promotes Osteoclastogenesis by Epigenetic Silencing of the Negative Regulator IRF8. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183582 DOI: 10.4049/Jimmunol.1501466  0.615
2015 Decker CE, Yang Z, Rimer R, Park-Min KH, Macaubas C, Mellins ED, Novack DV, Faccio R. Tmem178 acts in a novel negative feedback loop targeting NFATc1 to regulate bone mass. Proceedings of the National Academy of Sciences of the United States of America. PMID 26644563 DOI: 10.1073/Pnas.1511285112  0.456
2015 Lee MJ, Lim E, Mun S, Bae S, Murata K, Ivashkiv LB, Park-Min KH. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression. Journal of Cellular Physiology. PMID 26189496 DOI: 10.1002/Jcp.25091  0.7
2014 Park-Min KH, Lim E, Lee MJ, Park SH, Giannopoulou E, Yarilina A, van der Meulen M, Zhao B, Smithers N, Witherington J, Lee K, Tak PP, Prinjha RK, Ivashkiv LB. Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nature Communications. 5: 5418. PMID 25391636 DOI: 10.1038/Ncomms6418  0.752
2013 Issuree PD, Maretzky T, McIlwain DR, Monette S, Qing X, Lang PA, Swendeman SL, Park-Min KH, Binder N, Kalliolias GD, Yarilina A, Horiuchi K, Ivashkiv LB, Mak TW, Salmon JE, et al. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. The Journal of Clinical Investigation. 123: 928-32. PMID 23348744 DOI: 10.1172/Jci66168  0.62
2013 Lee A, Qiao Y, Grigoriev G, Chen J, Park-Min KH, Park SH, Ivashkiv LB, Kalliolias GD. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism. 65: 928-38. PMID 23335080 DOI: 10.1002/Art.37853  0.77
2013 Park-Min KH, Lee EY, Moskowitz NK, Lim E, Lee SK, Lorenzo JA, Huang C, Melnick AM, Purdue PE, Goldring SR, Ivashkiv LB. Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 135-49. PMID 22893614 DOI: 10.1002/Jbmr.1739  0.653
2012 Huynh L, Wang L, Shi C, Park-Min KH, Ivashkiv LB. ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes. Journal of Immunology (Baltimore, Md. : 1950). 188: 3447-57. PMID 22368279 DOI: 10.4049/Jimmunol.1102211  0.773
2011 Ivashkiv LB, Zhao B, Park-Min KH, Takami M. Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8. Annals of the New York Academy of Sciences. 1237: 88-94. PMID 22082370 DOI: 10.1111/J.1749-6632.2011.06217.X  0.681
2011 Park SH, Park-Min KH, Chen J, Hu X, Ivashkiv LB. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nature Immunology. 12: 607-15. PMID 21602809 DOI: 10.1038/Ni.2043  0.753
2010 Lee B, Kim TH, Jun JB, Yoo DH, Woo JH, Choi SJ, Lee YH, Song GG, Sohn J, Park-Min KH, Ivashkiv LB, Ji JD. Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. Journal of Immunology (Baltimore, Md. : 1950). 185: 5926-34. PMID 20935210 DOI: 10.4049/Jimmunol.1001591  0.601
2010 Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis and Rheumatism. 62: 402-13. PMID 20112358 DOI: 10.1002/Art.27200  0.641
2009 Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. Journal of Immunology (Baltimore, Md. : 1950). 183: 7223-33. PMID 19890054 DOI: 10.4049/Jimmunol.0900072  0.676
2009 Park-Min KH, Ji JD, Antoniv T, Reid AC, Silver RB, Humphrey MB, Nakamura M, Ivashkiv LB. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. Journal of Immunology (Baltimore, Md. : 1950). 183: 2444-55. PMID 19625651 DOI: 10.4049/Jimmunol.0804165  0.662
2009 Ji JD, Park-Min KH, Ivashkiv LB. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Human Immunology. 70: 211-7. PMID 19480842 DOI: 10.1016/J.Humimm.2009.01.026  0.626
2008 Hu Y, Park-Min KH, Yarilina A, Ivashkiv LB. Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2. Journal of Leukocyte Biology. 84: 1353-60. PMID 18678606 DOI: 10.1189/Jlb.0107040  0.67
2008 Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nature Immunology. 9: 378-87. PMID 18345002 DOI: 10.1038/Ni1576  0.72
2008 Wang L, Tassiulas I, Park-Min KH, Reid AC, Gil-Henn H, Schlessinger J, Baron R, Zhang JJ, Ivashkiv LB. 'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nature Immunology. 9: 186-93. PMID 18084294 DOI: 10.1038/Ni1548  0.655
2007 Tassiulas I, Park-Min KH, Hu Y, Kellerman L, Mevorach D, Ivashkiv LB. Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Human Immunology. 68: 156-64. PMID 17349870 DOI: 10.1016/J.Humimm.2006.12.008  0.713
2007 Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB. FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin Immunity. 26: 67-78. PMID 17239631 DOI: 10.1016/J.Immuni.2006.11.010  0.667
2005 Antoniv TT, Park-Min KH, Ivashkiv LB. Kinetics of IL-10-induced gene expression in human macrophages. Immunobiology. 210: 87-95. PMID 16164015 DOI: 10.1016/J.Imbio.2005.05.003  0.665
2005 Park-Min KH, Antoniv TT, Ivashkiv LB. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology. 210: 77-86. PMID 16164014 DOI: 10.1016/J.Imbio.2005.05.002  0.635
2005 Hu X, Park-Min KH, Ho HH, Ivashkiv LB. IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1. Journal of Immunology (Baltimore, Md. : 1950). 175: 3637-47. PMID 16148108 DOI: 10.4049/Jimmunol.175.6.3637  0.69
2003 Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, Tarakhovsky A, Pricop L, Salmon JE, Ivashkiv LB. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. The Journal of Experimental Medicine. 197: 1573-83. PMID 12782719 DOI: 10.1084/Jem.20021820  0.631
Show low-probability matches.